Aethlon Medical Financials

AEMD Stock  USD 0.37  0.02  5.71%   
Aethlon Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January. At present, Aethlon Medical's Total Current Liabilities is projected to decrease significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 6.1 M, whereas Net Debt is projected to grow to (4.3 M). Key indicators impacting Aethlon Medical's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio2.153.2504
Way Down
Slightly volatile
Investors should never underestimate Aethlon Medical's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Aethlon Medical's cash flow, debt, and profitability to make informed and accurate decisions about investing in Aethlon Medical.

Net Income

(11.6 Million)

  
Understanding current and past Aethlon Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Aethlon Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Aethlon Medical's assets may result in an increase in income on the income statement.
Please note, the presentation of Aethlon Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aethlon Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Aethlon Medical's management manipulating its earnings.

Aethlon Medical Stock Summary

Aethlon Medical competes with Tivic Health, Bluejay Diagnostics, Heart Test, Nuwellis, and Bone Biologics. Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company was founded in 1999 and is based in San Diego, California. Aethlon Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS00808Y3071
CUSIP00808Y307 00808Y208 00808Y406 00808Y109
LocationCalifornia; U.S.A
Business Address11555 Sorrento Valley
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.aethlonmedical.com
Phone619 941 0360
CurrencyUSD - US Dollar

Aethlon Medical Key Financial Ratios

Aethlon Medical Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets10.4M10.7M19.4M17.5M8.2M8.7M
Other Current Liab584.1K880.2K852.6K802.8K761.5K723.4K
Net Debt(9.5M)(9.8M)(16.3M)(13.3M)(4.5M)(4.3M)
Retained Earnings(112.0M)(119.9M)(130.3M)(142.4M)(154.6M)(146.8M)
Cash9.6M9.9M17.1M14.5M5.4M3.0M
Total Liab1.1M1.4M2.4M2.4M2.5M4.1M
Total Current Assets10.0M10.4M18.2M15.1M5.9M3.2M
Common Stock9.4K12.2K15.4K23.0K2.6K2.5K
Accounts Payable285.0K337.7K500.0K432.9K777.9K566.0K
Intangible Assets57.5K57.0K2.2K1.7K1.1K1.0K
Other Current Assets229.6M341.1K1.9M557.6K506.0K480.7K
Short Term Debt98.6K42.5K126.9K269.4K290.6K276.0K
Net Tangible Assets9.4M9.4M17.1M15.1M17.3M18.2M
Capital Surpluse105.6M108.1M121.4M129.3M148.7M97.7M

Aethlon Medical Key Income Statement Accounts

201920202021202220232024 (projected)
Interest Expense54.2K1.6K123.7K131.1M150.8M158.4M
Operating Income(5.9M)(7.9M)(10.4M)(11.9M)(12.6M)(12.0M)
Ebit(5.9M)(7.9M)(10.4M)(11.9M)(12.2M)(11.6M)
Ebitda(5.9M)(7.8M)(10.3M)(11.7M)(11.8M)(11.3M)
Net Income(6.4M)(7.8M)(10.4M)(12.0M)(12.2M)(11.6M)
Income Tax Expense48.1K(43.1K)(4.8K)131.1M3.02.85
Gross Profit650.2K659.1K294.2K308.9K(359.1K)(377.0K)
Cost Of Revenue2.3B3.5B4.6B265.3K359.1K341.1K
Income Before Tax(6.4M)(7.9M)(10.4M)(12.0M)(12.2M)(12.8M)
Research Development927K2.1M2.3M2.7M2.5M2.6M
Total Revenue229.6K650.2K659.1K294.2K574.2K0.0
Minority Interest(6.1K)(136.9K)4.8K620.0713.0748.65
Interest Income220.5K54.2K0.011.0K428.4K243.0K
Net Interest Income(54.2K)(1.6K)0.011.0K428.4K449.8K

Aethlon Medical Key Cash Accounts

201920202021202220232024 (projected)
Change In Cash5.8M303.5K7.3M(2.5M)(9.1M)(8.6M)
Free Cash Flow(5.3M)(6.8M)(10.1M)(11.4M)(10.4M)(9.9M)
Other Non Cash Items31.3K(2.5K)30.5K(46.6M)21.3K22.3K
Net Income(6.4M)(7.9M)(10.4M)(12.0M)(12.2M)(11.6M)
End Period Cash Flow9.6M9.9M17.2M14.6M5.5M3.0M
Depreciation26.4K39.9K123.7K240.9K359.1K377.0K
Change To Inventory(74.8K)8.5K(104.7K)456.6K411.0K431.5K
Change Receivables(74.8K)74.8K(206.7K)57.6K66.3K69.6K
Change To Netincome1.2M772.1K776.4K1.2M1.1M1.6M
Investments(151.7K)(59.9K)(349.2K)(943.1K)(250.9K)(263.4K)

Aethlon Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Aethlon Medical's current stock value. Our valuation model uses many indicators to compare Aethlon Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aethlon Medical competition to find correlations between indicators driving Aethlon Medical's intrinsic value. More Info.
Aethlon Medical is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Aethlon Medical's Return On Equity is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Aethlon Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Aethlon Medical Systematic Risk

Aethlon Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Aethlon Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Aethlon Medical correlated with the market. If Beta is less than 0 Aethlon Medical generally moves in the opposite direction as compared to the market. If Aethlon Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Aethlon Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Aethlon Medical is generally in the same direction as the market. If Beta > 1 Aethlon Medical moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Aethlon Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Aethlon Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Aethlon Medical growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.0198

At present, Aethlon Medical's Price Earnings To Growth Ratio is projected to increase significantly based on the last few years of reporting.

Aethlon Medical December 18, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Aethlon Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Aethlon Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aethlon Medical based on widely used predictive technical indicators. In general, we focus on analyzing Aethlon Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aethlon Medical's daily price indicators and compare them against related drivers.

Complementary Tools for Aethlon Stock analysis

When running Aethlon Medical's price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments